• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Tissue inhibitor of metalloproteinases-1 in chronic liver disease.

Research Project

Project/Area Number 06670553
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTottori University

Principal Investigator

MURAWAKI Yoshikazu  Tottori University, Second Department of Internal Medicine, Assistant Professor, 医学部・附属病院, 講師 (90144659)

Project Period (FY) 1994 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1996: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1995: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1994: ¥800,000 (Direct Cost: ¥800,000)
KeywordsLiver disease / TIMP / 慢性肝疾患 / TIMP-1
Research Abstract

Tissue inhibitor of metalloproteinases (TIMP) -1 is an important regulator of matrix metalloproteinase activity. Recently, we have demonstrated that the serum levels of TIMP-1 are increased in patients with chronic active liver disease, correlating with the histological degree of liver fibrosis. To clarify the changes in TIMP-1 in diseased livers, we measured TIMP-1 concentrations in liver tissue samples from patients with chronic liver disease. We carried out an immunohistochemical staining for TIMP-1. The relationship between serum and liver levels of TIMP-1 was examined in some patients. As compared with the controls, the mean liver TIMP-1 level was increased 2.2-fold in chronic active hepatitis 2A patients, 2.9-fold in chronic active hepatitis 2B patients and 4.1-fold in liver cirrhosis patients, but no significant increase was observed among chronic persistent hepatitis patients. The liver TIMP-1 levels were closely correlated with the histological degrees of periportal necrosis, … More portal inflammation, and liver fibrosis. When the localization of TIMP-1 was examined immunohistochemically, TIMP-1 was stained mainly in hepatocytes, and the intensity was stronger in the livers of chronic active hepatitis and liver cirrhosis patients than in those of the chronic persistent hepatitis patients. The serum TIMP-1 and liver TIMP-1 levels were significantly correlated, indicating that serum TIMP-1 could reflect the change of liver TIMP-1 in patients with chronic liver disease. Gelfiltrattion of liver extract and plasma showed that the major peak of TIMP-1 in both samples was eluted at around 40 kDa, indicating that TIMP-1 is present as TIMP-1 complexed with a small protein which is probably a fragment of MMP.Transforming growth factor (TGF) -beta1 is an important cytokine involved in the production of TIMP-1. Plasma TGF-beta1 levels were positively correlated with blood levels of TIMP-1
In conclusion, the liver TIMP-1 concentration increased with the progress of liver disease, where the degradation of extracellular matrix proteins is decreased, resulting in the development of liver fibrosis. Less

Report

(4 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • 1994 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Yoshikazu Murawaki: "Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease." Journal of Hepatology. 26 (in press). (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Yoshikazu Murawaki: "Characterization of tissue inhibitor of metalloproteinase-1 in plasma from patients with chronic liver disease" Clinica Chimica Acta. 254. 77-83 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Yoshikazu Murawaki: "Serum markers for fibrosis and plasma transforming growth factor-β1 in pathients with hepatocellular carcinoma in comparison with patients with liver cirrhosis." Journal of Gastroenterology and Hepathology. 11. 443-450 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 村脇義和: "肝線維化と血漿TGF-β1" 薬理と治療. 24. S111-S116 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Yoshikazu Murawaki: "Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C・A comparative analysis." Journal of Hepatology. 23. 145-152 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Murawaki Y,Ikuta Y,Idobe Y,Kitamura Y,Kawasaki H: "Tissue inhibitor of metalloproteinases-1 in the liver of patients with chronic liver disease" J Hepatol. (in press). (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Murawaki Y,Ikuta Y,Idobe Y,Kawasaki H: "Characterization of tissue inhibitor of metalloproteinases-1 in plasama from patients with chronic liver disease." Clin Chim Acta. 254. 77-83 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Murawaki Y,Ikuta Y,Nishimura Y,Koda M,Kawasaki H: "Serum markers for fibrosis and plasma transforming growth factor-beta-1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis." J Gastroenterol Hepatol. 11. 443-450 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Murawaki Y,Ikuta Y,Nishimura Y,Koda M,Kawasaki H: "Plasma TGF-beta1 and liver fibrosis (in Japanese)" Jpn Pharmacol Ther. 24. s111-s116 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Murawaki Y,Ikuta Y,Nishimura Y,Koda M,Kawasaki H: "Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C : A comparative analysis." J Hepatol. 23. 145-152 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Yoshikazu Murawaki: "Tissue inhibitor of metalloproteinase-1 in the liver of patieats with chronic liver disease." Journal of Hepatology. 26(in press). (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshikazu Murawaki: "Characterization of tissue inhibitor of metalloproteinases-1 in plasma from patients with chronic liver disease." Clinica Chimica Acta. 254. 77-83 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshikazu Murawaki: "Seram markers for fibrosis and plasma transforming growth factor-β1 in patients with hepatocellular carcinoma in comparison with patients with liver cinhisis." Journal of Gastroenterology and Hepatology. 11. 443-450 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] 村脇 義和: "肝線維化と血漿TGF-β1" 薬理と治療. 24. S111-S116 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Yoshikazu Murawaki: "Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C:a comparative analysis." Journal of Hepatology. 23. 145-152 (1995)

    • Related Report
      1996 Annual Research Report
  • [Publications] 村脇 義和: "肝細胞癌におけるコラーゲン代謝" 薬理と治療. 23. S785-S793 (1995)

    • Related Report
      1996 Annual Research Report
  • [Publications] 村脇 義和: "肝細胞癌におけるコラーゲン代謝" 薬理と治療. 23. S785-S793 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Yoshikazu Murawaki: "Serum markers for connective tissue turn over in patients with chronic hepatitis B and chronic hepatitic C : A comparative analysis" J Hepatol. 23. 145-152 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] 村脇 義和: "肝線維化と血漿TGF-β1" 薬理と治療. 24. S111-S116 (1996)

    • Related Report
      1995 Annual Research Report
  • [Publications] Yoshikazu Murawaki: "Serum markers for fibrosis and plasma transforming growth factor-β1 in patients with hepatocellular carcinoma in comparison with patients with liver cirvhosis" J Gastroenterol Hepatol. (in press). (1996)

    • Related Report
      1995 Annual Research Report
  • [Publications] 村脇義和: "肝細胞癌におけるコラーゲン代謝" 薬理と治療. 23. S785-S793 (1995)

    • Related Report
      1994 Annual Research Report

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi